Back to Search
GERALD KRUEGER, M.D.
M.D.
Dermatology Physician
NPI: 1578661302Individual
Specialties, Licenses & Credentials
Procedural Dermatology Physician
Dermatology — Procedural Dermatology
Code: 207NS0135X
1539961205(UT)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
1539961205(UT)
Research & Publications (20)
A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
PMID 18569270·J Dermatolog Treat·2008
3-trial
Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.
PMID 17373177·J Drugs Dermatol·2007
3-trial
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
PMID 17287478·N Engl J Med·2007
3-trial
Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial.
PMID 16488321·J Am Acad Dermatol·2006
8-other
Psoriasis--recent advances in understanding its pathogenesis and treatment.
PMID 15968269·J Am Acad Dermatol·2005
6-review
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
PMID 16307657·Br J Dermatol·2005
3-trial
Current concepts and review of alefacept in the treatment of psoriasis.
PMID 15450337·Dermatol Clin·2004
4-observational
Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
PMID 14967799·Arch Dermatol·2004
6-review
Alefacept therapy produces remission for patients with chronic plaque psoriasis.
PMID 12752139·Br J Dermatol·2003
3-trial
Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis.
PMID 12795771·J Eur Acad Dermatol Venereol·2003
3-trial
Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
PMID 11955280·Expert Opin Biol Ther·2002
6-review
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.
PMID 12451365·J Am Acad Dermatol·2002
3-trial
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
PMID 11255325·Arch Dermatol·2001
8-other
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
PMID 10906652·J Am Acad Dermatol·2000
8-other
The formation of the American Society of Clinical Oncology and the development of a medical specialty, 1964-1973.
PMID 15467176·Perspect Biol Med·2004
8-other
Human herpesvirus-6: a short review of its biological behavior.
PMID 14555846·Intervirology·2003
6-review
Multiple Loci within the major histocompatibility complex confer risk of psoriasis.
PMID 19680446·PLoS Genet·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 50 N MEDICAL DR
SALT LAKE CITY, UT 84132 - Phone
- (801) 581-2955
Quick Facts
- NPI
- 1578661302
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile